Clinical Trial Update: Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating empagliflozin for euvolemic and hypervolemic hyponatremia (including SIADH); recruitment is ongoing at University Hospital Bas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hyponatremia, SIADH | Phase 4 | Status: RECRUITING